A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin

Summary

This multi-center, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy, safety and tolerability of RO6811135 in Type 2 diabetic patients treated with a stable dose of metformin.

Timeline

Start

2013-12

Primary completion

2013-12

Completion

2013-12

Outcome

Outcome not reported

Stopped: “Cancelled due to Sponsor's decision”

Drugs

Indications